Matches in Nanopublications for { ?s ?p "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP490636.RAYIDCDUInvw1DcsZRrkkHqelh2kPNXFGy27NQM22gWX4130_assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490636.RAYIDCDUInvw1DcsZRrkkHqelh2kPNXFGy27NQM22gWX4130_provenance.
- NP408280.RAq9amVJQbg0kFDgf-qe77nXqdj69Mgdu15wF8g_bJzpU130_assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408280.RAq9amVJQbg0kFDgf-qe77nXqdj69Mgdu15wF8g_bJzpU130_provenance.
- NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408290.RAKbvvYafd2JDyOiNxQEtyxxjGJ_Iy3U1rt2FiQXClWS8130_provenance.
- NP490635.RAPYFZBgLurC6hFKAcUKRNmqxr9NgssnzVaH5ICMMeFVI130_assertion description "[The authors previously reported the results of a clinical trial in which some patients with metastatic prostate cancer treated with flt3 ligand developed autoimmune hypothyroidism with thyroid-specific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490635.RAPYFZBgLurC6hFKAcUKRNmqxr9NgssnzVaH5ICMMeFVI130_provenance.